Everything tagged "cash flow" across research, earnings, and macro.
113 articles
Booz Allen Hamilton looks undervalued after a rough revenue year, with strong cash generation, a $38.187B backlog, and growing cyber and defense tech exposure.
Reddit has evolved into a high-growth, cash-generative ad platform with strong margins and accelerating monetization. The stock still trades at a rich multiple, so the upside depends on continued execution in ads, search, and international expansion.
TopBuild combined strong cash generation and scale with softer housing demand and rising leverage after its acquisition wave. The report stays constructive, but the stock now looks like an execution story rather than a clean cyclical rebound.
Newmont pairs record cash generation with a net cash balance sheet and a $6B buyback, making it a compelling gold exposure. The main risks are gold-price sensitivity, cost inflation, and operational noise, but the stock still screens attractively versus its fair value.
Comfort Systems USA is firing on all cylinders, with record backlog, surging data center demand, and sharply higher margins driving a Buy case. Valuation is rich, but execution and cash generation remain exceptional.
VeriSign remains a rare internet infrastructure monopoly with recurring demand, pricing power, and strong cash conversion. The stock’s quality is clear, but the valuation already reflects much of that strength, supporting a Hold view.
Rollins remains a high-quality compounder with recurring demand, strong cash flow, and broad service-line diversification. The stock still earns a Buy, but softer Q2 momentum and a rich multiple keep the upside tied to discipline on price.
Masco combines strong free cash flow, improving Q1 2026 margins, and a raised capital deployment plan with ongoing housing-cycle and tariff exposure. The stock looks respectable rather than cheap, making execution and cash generation the key debate.
Thermo Fisher remains a scaled, resilient life sciences compounder with strong cash generation and raised 2026 guidance. The stock looks attractive on quality, but valuation and leverage argue for patience rather than chasing it higher.
EQT is pairing strong cash flow with a faster-deleveraging balance sheet and new long-term gas contracts. The report argues the stock is a disciplined Buy for moderate-risk investors.
Penske Automotive Group combines strong free cash flow, a resilient service-and-parts mix, and active portfolio upgrades, but leverage and softer earnings keep the stock from looking cheap on every metric.
Medpace is still delivering strong revenue, margin, and cash flow growth, but softer bookings and a rich valuation keep the stock in Hold territory. The business quality is high, yet the current setup looks better on pullbacks than at full price.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator